Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1645 studies found for:    "Hepatitis, Chronic"
Show Display Options
Download search resultsDownload the search results for:
"Hepatitis, Chronic" (1645 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed Treatment of Chronic Hepatitis With Sofosbuvir in Combination With Ribavirin With or Without Pegylated Interferon: North India Gastroenterology Consortium
Condition: Hepatitis, Chronic
Intervention: Drug: Sofosbuvir, Ribavirin, With or Without Pegylated Interferon
2 Completed Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis C
Condition: Hepatitis, Chronic
Intervention:
3 Terminated Telbivudine Versus Lamivudine for Maintenance Therapy of Patients With Chronic Hepatitis B and Negative HBV Viral Load After 6 Month of Treatment With Telbivudine
Condition: Hepatitis, Chronic
Interventions: Drug: Lamivudine;   Drug: Telbivudine
4 Completed Patient Self-management and Gene Guided Therapy for Chronic Hepatitis C
Condition: Chronic Hepatitis C
Intervention:
5 Completed Study of Nitazoxanide in the Treatment of Chronic Hepatitis C
Condition: Chronic Hepatitis C
Intervention: Drug: Nitazoxanide
6 Terminated Plasma Ribavirin Assay During Combination Therapy for Chronic Hepatitis C
Condition: Chronic Hepatitis C
Intervention: Procedure: therapeutic drug monitoring of ribavirin and dose adaptation
7 Active, not recruiting The Optimizing Treatment of Peginterferon (PEG IFN) Alpha in Chronic Hepatitis B Virus Patients With Low Level HBsAg
Condition: Chronic Hepatitis B
Intervention: Drug: peginterferon alfa
8 Recruiting Sustained Off-treatment Response After HBeAg Loss in Chronic Hepatitis B Patients Treated With Nucleos(t)Ide Analogues
Condition: Chronic Hepatitis B
Interventions: Drug: Continue NA treatment;   Drug: Discontinue NA Treatment
9 Completed CHARM: Chronic Hepatitis B Antihepadnaviral Resistance Mutation Study
Condition: Chronic Hepatitis B
Intervention: Other: No intervention
10 Recruiting The Safety and Dose-range Study of Metacavir Enteric-coated Capsules in Patients With Chronic Hepatitis B
Condition: Chronic Hepatitis B
Interventions: Drug: Metacavir Enteric-coated Capsules 80mg;   Drug: Metacavir Enteric-coated Capsules 160mg;   Drug: Metacavir Enteric-coated Capsules 320mg;   Drug: Metacavir Enteric-coated Capsules Placebo 240mg;   Drug: Metacavir Enteric-coated Capsules Placebo 160mg;   Drug: Metacavir Enteric-coated Capsules Placebo 320mg;   Drug: Adefovir Dipivoxil Capsule10mg;   Drug: Adefovir Dipivoxil Capsule Placebo 10mg
11 Completed
Has Results
Efficacy and Safety Study of Ursodeoxycholic Acid to Treat Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Ursodeoxycholic acid 150mg / day;   Drug: Ursodeoxycholic acid 600mg / day;   Drug: Ursodeoxycholic acid 900mg / day
12 Recruiting Mechanisms Associated With Favorable Responses to Peginterferon-Alpha Add-on Therapy Following Long-term Nucleos(t)Ide Analogue Treatment in Patients With Chronic Hepatitis B
Condition: Chronic Hepatitis B
Intervention: Drug: Peginterferon alfa-2a
13 Completed Effect of Camel Milk on Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Drug: Peginterferon, Ribavirin, camel milk;   Drug: Peginterferon, Ribavirin
14 Completed Evaluation of RNA From the Liver Tissue Obtained in Patients With Chronic Hepatitis C (0000-123)
Condition: Chronic Hepatitis C
Intervention: Procedure: Comparator: Fine needle aspiration biopsy
15 Unknown  Therapeutic Hepatitis B Vaccine (Synthesized Peptide) in Treating Chronic Hepatitis B Patients
Condition: Chronic Hepatitis B
Interventions: Biological: The therapeutic (synthesized peptide) HBV vaccine (εPA-44);   Biological: Placebo
16 Recruiting Therapeutic Effects and Long-term Follow-up After Ending Nucleos(t)Ide Analogs Therapy in Chronic Hepatitis b
Condition: Chronic Hepatitis b
Intervention: Drug: Entecavir or Tenofovir
17 Completed Efficacy Study of Thymosin alpha1 & Pegylated Interferon-alpha2a to Treat Chronic Hepatitis B
Condition: Chronic Hepatitis B
Interventions: Drug: Pegylated Interferon-alpha2a;   Drug: Thymosin alpha1 & Pegylated Interferon-alpha2a
18 Completed Albinterferon Alfa 2b Single Dose in Japanese Chronic Hepatitis C Patients
Condition: Chronic Hepatitis C
Intervention: Biological: Albinterferon alfa 2b
19 Terminated Effects of Genotypes on Interferon Signaling in Chronic Hepatitis C
Condition: Chronic Hepatitis C
Interventions: Procedure: Blood sampling of peripheral blood mononuclear cells;   Procedure: Blood draw, 20ml peripheral blood mononuclear cells
20 Terminated Safety and Antiviral Study of ACH-126, 443 (Beta-L-Fd4C) in the Treatment of Adults With Chronic Hepatitis B Infection.
Condition: Chronic Hepatitis B
Intervention: Drug: ACH-126, 443 (beta-L-Fd4C)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.